Read the Docket, Beat the Market: How Litigation Data Tells You When a Generic Drug Will Launch
In the high-stakes world of pharmaceuticals, timing isn’t just everything—it’s the game-changer. For brand-name drug manufacturers, the looming threat of generic competition can mean the difference between thriving and surviving. Yet, despite the criti…
